Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy

NCT01504711 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Cancer
Nausea Post Chemotherapy

Interventions

DRUG: fosaprepitant dimeglumine

Sponsor

Philip Philip

Collaborators

[object Object]